본문 바로가기

Company

History

Jeisys Medical History

One of the Top Leaders in USA, Japan

GlobalExpansion
2024
  • · Appointment of CEO Rami Lee
2023
  • · Density launching
    · Establishment of Vietnam branch (in Hanoi)
    · Received the $70 Million Export Tower Award
2022
  • · Linear Z launching
    · Establishment of Australia branch (in Melbourne)
    · Received the $50 Million Export Tower Award
2021
  • · Listed in KOSDAQ
    · Establishment of Saccibio
2020
  • · Received the $20 Million Export Tower Award
    · POTENZA US FDA / Europe CE / Brazil Anvisa approval
2019
  • · POTENZA launching
    · Signed a supply contract with Cynosure LLC
    · LIPOcel, US FDA approval

Pioneer in K-beauty Medical Device,
by Penetrating the Asian Market

Growth2013~2018
2018
  • · ULTRAcel Q+ system launching
    · Edge ONE, Japan PMDA approval
2017
  • ·  INTRAcel PRO™ launching
    ·  Cellec V launching
    ·  Edge ONE, Europe CE approval
2016
  • · INTRAcel / Edge ONE, US FDA approval
2015
  • · Establishment of Japan branch (in Tokyo)
    · ULTRAcel, Europe CE approval
2014
  • · Selected as the 66th 'Trader of the Month' (Kang Dong Hwan, CEO)
    · Received the $10 Million Export Tower Award
    · ULTRAcel launching
2013
  • · IntraGen launching
    · Edge ONE launching
    · TRI-BEAM / Edge, US FDA approval

Globally Recognized Technology,
with Approval from FDA, CE, MDSAP

Take-off2007~2012
2012
  • · SmoothCool launching
    · TRI-BEAM, Europe CE approval
2011
  • · TRI-BEAM Premium™: Dual Pulse Q-Switched Nd:YAG laser MFDS approval
    · Cellec™: Multi-function replacement filter, MFDS approval
2010
  • · Plasma D30/LIPO US FDA approval
2009
  • · INTRAcel launching
    · Grid RF/CO2 Laser launching
2008
  • · Selected as an INNO-BIZ Grade A technology innovative small and medium-sized enterprise
    · SmoothCool Europe CE / US FDA approval
2007
  • · Plasma D30: MFDS obtaining - Plasma light system
    · AntiLax : MFDS approval by IR/RF Non-ablative combination

The Start of the New Era as a Global Leader

Creation2001~2005
2005
  • · Selected as a venture company eligible for technology guarantee fund
    · P-NAIN Europe CE / US FDA approval
2004
  • · Establishment of Jeisys Medical (corporate conversion)
    · Establishment of R&D center (company-affiliated research institute)
    · ISO 9001:2000, KSA9001:2001 & ISO-13485:2003 quality system certification
2003
  • · P-NAIN-IPL: ATC technology utilized product acquired MFDS
2001
  • · Establishment of ‘Jeisys’ (individual business)